A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT05242484 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05242484
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2025-05-15
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.